1. Home
  2. ALLR vs IDAI Comparison

ALLR vs IDAI Comparison

Compare ALLR & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • IDAI
  • Stock Information
  • Founded
  • ALLR 2004
  • IDAI 2016
  • Country
  • ALLR United States
  • IDAI United States
  • Employees
  • ALLR N/A
  • IDAI N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • IDAI Computer Software: Prepackaged Software
  • Sector
  • ALLR Health Care
  • IDAI Technology
  • Exchange
  • ALLR Nasdaq
  • IDAI Nasdaq
  • Market Cap
  • ALLR 4.5M
  • IDAI 4.2M
  • IPO Year
  • ALLR N/A
  • IDAI N/A
  • Fundamental
  • Price
  • ALLR $1.05
  • IDAI $0.39
  • Analyst Decision
  • ALLR
  • IDAI
  • Analyst Count
  • ALLR 0
  • IDAI 0
  • Target Price
  • ALLR N/A
  • IDAI N/A
  • AVG Volume (30 Days)
  • ALLR 218.5K
  • IDAI 52.2M
  • Earning Date
  • ALLR 11-14-2024
  • IDAI 11-15-2024
  • Dividend Yield
  • ALLR N/A
  • IDAI N/A
  • EPS Growth
  • ALLR N/A
  • IDAI N/A
  • EPS
  • ALLR N/A
  • IDAI N/A
  • Revenue
  • ALLR N/A
  • IDAI $2,160,186.00
  • Revenue This Year
  • ALLR N/A
  • IDAI N/A
  • Revenue Next Year
  • ALLR N/A
  • IDAI $95.88
  • P/E Ratio
  • ALLR N/A
  • IDAI N/A
  • Revenue Growth
  • ALLR N/A
  • IDAI N/A
  • 52 Week Low
  • ALLR $0.90
  • IDAI $0.15
  • 52 Week High
  • ALLR $378.00
  • IDAI $2.50
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 39.84
  • IDAI 50.82
  • Support Level
  • ALLR $0.90
  • IDAI $0.36
  • Resistance Level
  • ALLR $1.14
  • IDAI $0.44
  • Average True Range (ATR)
  • ALLR 0.08
  • IDAI 0.13
  • MACD
  • ALLR 0.02
  • IDAI -0.02
  • Stochastic Oscillator
  • ALLR 66.67
  • IDAI 10.53

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility.

Share on Social Networks: